163 related articles for article (PubMed ID: 21856036)
1. Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.
Fan H; Tansi FL; Weihofen WA; Böttcher C; Hu J; Martinez J; Saenger W; Reutter W
Eur J Cell Biol; 2012 Apr; 91(4):265-73. PubMed ID: 21856036
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
[TBL] [Abstract][Full Text] [Related]
3. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
[TBL] [Abstract][Full Text] [Related]
5. Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells.
Tansi FL; Blanchard V; Berger M; Tauber R; Reutter W; Fan H
Virol J; 2010 Oct; 7():267. PubMed ID: 20942971
[TBL] [Abstract][Full Text] [Related]
6. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
Hühn J; Olek S; Fleischer B; von Bonin A
Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
[TBL] [Abstract][Full Text] [Related]
7. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface.
Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
J Biol Chem; 2004 Oct; 279(41):43330-5. PubMed ID: 15213224
[TBL] [Abstract][Full Text] [Related]
9. 3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis.
Ludwig K; Fan H; Dobers J; Berger M; Reutter W; Böttcher C
Biochem Biophys Res Commun; 2004 Jan; 313(2):223-9. PubMed ID: 14684150
[TBL] [Abstract][Full Text] [Related]
10. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD
Eur J Biochem; 1999 Dec; 266(3):798-810. PubMed ID: 10583373
[TBL] [Abstract][Full Text] [Related]
11. Citrullination of adenosine deaminase impairs its binding to dipeptidyl peptidase IV.
Karapetyan L; Sharoyan S; Mardanyan S; Lupidi G; Cuccioloni M; Angeletti M; Markarian S; Shilajyan H; Antonyan A
Biophys Chem; 2022 Jul; 286():106820. PubMed ID: 35468399
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of human dipeptidyl peptidase IV expressed in Pichia pastoris. A structural and mechanistic comparison between the recombinant human and the purified porcine enzyme.
Bär J; Weber A; Hoffmann T; Stork J; Wermann M; Wagner L; Aust S; Gerhartz B; Demuth HU
Biol Chem; 2003 Dec; 384(12):1553-63. PubMed ID: 14719797
[TBL] [Abstract][Full Text] [Related]
14. Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis.
Yu DM; Wang XM; McCaughan GW; Gorrell MD
FEBS J; 2006 Jun; 273(11):2447-60. PubMed ID: 16704418
[TBL] [Abstract][Full Text] [Related]
15. Good or evil: CD26 and HIV infection.
Ohtsuki T; Tsuda H; Morimoto C
J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD26 and its association with dipeptidyl peptidase IV activity in lymphocytes of type 2 diabetes patients.
Bellé LP; Bitencourt PE; de Bona KS; Zanette RA; Moresco RN; Moretto MB
Cell Biochem Biophys; 2011 Nov; 61(2):297-302. PubMed ID: 21614532
[TBL] [Abstract][Full Text] [Related]
17. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
18. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.
Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ
Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139
[TBL] [Abstract][Full Text] [Related]
19. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
20. On the regulatory role of dipeptidyl peptidase IV (=CD=adenosine deaminase complexing protein) on adenosine deaminase activity.
Ben-Shooshan I; Kessel A; Ben-Tal N; Cohen-Luria R; Parola AH
Biochim Biophys Acta; 2002 May; 1587(1):21-30. PubMed ID: 12009420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]